Error loading player: No playable sources found

4425

Cholestatic Liver Disease

Date
May 5, 2025
This product is not available for individual purchase, but it is available as part of the following products:
Thumbnail for DDW 2025 - Full Program On Demand
Don't miss the opportunity to access the latest research and discoveries in the field of digestive diseases. DDW On Demand is a valuable and convenient way to enhance your knowledge and skills in digestive disease care…

Society: AGA/AASLD

This session will cover a range of topics, including the risks associated with GLP-1 receptor agonist therapy, the treatment of cholestatic pruritus with Volixibat, and the global burden of chronic liver disease. Attendees will also learn about the role of the ADAM9 gene in cholangiocarcinoma, the impact of obesity on acute liver failure outcomes, and the potential benefits of lipid-lowering therapy in primary sclerosing cholangitis.

Moderators

Speaker Image for Olumuyiwa Awoniyi
Cleveland Clinic
Speaker Image for John Martin
Mayo Clinic